Glaukos Corp
NYSE:GKOS

Watchlist Manager
Glaukos Corp Logo
Glaukos Corp
NYSE:GKOS
Watchlist
Price: 138.62 USD -3.23% Market Closed
Market Cap: 7.6B USD
Have any thoughts about
Glaukos Corp?
Write Note

Glaukos Corp
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Glaukos Corp
Cash Equivalents Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Glaukos Corp
NYSE:GKOS
Cash Equivalents
$100.1m
CAGR 3-Years
-4%
CAGR 5-Years
20%
CAGR 10-Years
47%
Becton Dickinson and Co
NYSE:BDX
Cash Equivalents
$1.7B
CAGR 3-Years
-9%
CAGR 5-Years
26%
CAGR 10-Years
-1%
Boston Scientific Corp
NYSE:BSX
Cash Equivalents
$2.5B
CAGR 3-Years
9%
CAGR 5-Years
55%
CAGR 10-Years
26%
Stryker Corp
NYSE:SYK
Cash Equivalents
$3.9B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
11%
Abbott Laboratories
NYSE:ABT
Cash Equivalents
$7B
CAGR 3-Years
-9%
CAGR 5-Years
11%
CAGR 10-Years
7%
Intuitive Surgical Inc
NASDAQ:ISRG
Cash Equivalents
$1.8B
CAGR 3-Years
32%
CAGR 5-Years
23%
CAGR 10-Years
14%

See Also

What is Glaukos Corp's Cash Equivalents?
Cash Equivalents
100.1m USD

Based on the financial report for Sep 30, 2024, Glaukos Corp's Cash Equivalents amounts to 100.1m USD.

What is Glaukos Corp's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
47%

Over the last year, the Cash Equivalents growth was -8%. The average annual Cash Equivalents growth rates for Glaukos Corp have been -4% over the past three years , 20% over the past five years , and 47% over the past ten years .

Back to Top